This site is intended for healthcare professionals only
LoginRegister
AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitorAstraZeneca Pharma India bags CDSCO nod for expanded use of Trastuzumab Deruxtecan in HER2-Positive...
Breaking News: Health Ministry Bans Immediate-Release Nimesulide Oral Doses Above 100 mgColdrif Cough Syrup banned in Punjab amid child deaths
Contaminated cough syrup tragedy: NHRC steps in, demands investigationContaminated cough syrup tragedy: NHRC steps in, demands investigation
Over 17000 Jan Aushadhi Kendras opened nationwide till November 30: Minister tells ParliamentDoP identifies 11,100 Jan Aushadhi Kendras across India as Outdoor Cleaning Sites
Biocon unveils Liraglutide for diabetes, obesity in NetherlandsBiocon Pharma, Carnegie Pharma gain USFDA tentative nod for Rifaximin Tablets to treat irritable...
Eli Lilly plans to invest over USD 1 billion in new contract manufacturing in IndiaEli Lilly plans to invest over USD 1 billion in new contract manufacturing in India
NPPA Uses Pharma Sahi Daam App to Track Drug Price Violations, Parliament InformedPrice Cap Exemption Pending: NPPA Refers Biodeal Pharma's Midazolam Nasal Spray to CDSCO, SNCM for...
CDSCO Panel Seeks Revised Phase IV Study for Zydus Empagliflozin, Metformin FDCZydus Gets CDSCO Panel Nod for Phase III Trial of Dextromethorphan, Phenylephrine Cough Syrup FDC
Show cause notices issued to 196 retail medical shops in TelanganaToxic Coldrif Fallout: Tamil Nadu Govt Issues Show-Cause Notice to Sresan Pharma, License at Risk
Pharma Education on Rise: Telangana Sees 96% B.Pharm Seat Fill-Up in TG EAPCET 2025Maharashtra B.Pharm Admissions 2025: 29,166 Students Allotted Seats in First Round
ZydusZydus Lifesciences gets NOC from Health Canada for hypothyroidism tablets
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusZydus Lifesciences secures USFDA okay for Duchenne Muscular Dystrophy drug
X